Patrick J. Christmas - 01 Nov 2026 Form 4 Insider Report for REGENXBIO Inc. (RGNX)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
03 Nov 2026, 16:32:22 UTC
Prior SEC filing
04 Aug 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Patrick J. Christmas
Filing notes and source

Key filing fact

Patrick J. Christmas filed Form 4 for REGENXBIO Inc. (RGNX) on 03 Nov 2026.

Key facts

  • This page summarizes Patrick J. Christmas's Form 4 filing for REGENXBIO Inc. (RGNX).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 03 Nov 2026, 16:32.

Change

  • Previous filing in this sequence was filed on 04 Aug 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001521123 Primary reporting owner

Christmas Patrick J.

Relationship
Chief Strategy & Legal Officer
Address
C/O REGENXBIO INC., 9804 MEDICAL CENTER DRIVE, ROCKVILLE
Signature
/s/ Patrick J. Christmas
Signature date
03 Nov 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

RGNX transaction

Common Stock

Award

Transaction value
Shares
+34,722
Change %
+17%
Price
$0.000000*
Shares after
240,690
Date
01 Nov 2026
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 1/3rd of the shares subject to the RSU award shall vest on each of November 1, 2027, November 1, 2028, and November 1, 2029, while the recipient provides continuous service to the Issuer.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .